Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients

Se Jung Yoon, Sungha Park, Chanmi Park, Woochul Chang, Deok Kyu Cho, Young Guk Ko, Donghoon Choi, Hyuck Moon Kwon, Yangsoo Jang, Namsik Chung

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

OBJECTIVES: In humans, a secreted isoform of (soluble) receptor for advanced glycation end-products (sRAGE) may act as a decoy receptor of advanced glycation end-product. The level of sRAGE may reflect the activity of cell surface receptor for advanced glycation end-product. But there has been no study that has demonstrated the association of sRAGE with central aortic stiffness. Here, we studied the relation of plasma sRAGE level and arterial pulse wave velocity in hypertensive patients. MATERIALS AND METHODS: A total of 415 patients were enrolled (men; 57.6%, mean age; 53.2±10.8 years), with 25.8% (n=107) of these being diabetic. All patients underwent pulse wave velocity (PWV) and blood sampling of sRAGE, high-sensitive C-reactive protein, and other serologic markers. RESULTS: The log-transformed sRAGE was significantly correlated with the marker of central aortic stiffness heart to femoral PWV (hfPWV; r=0.165, P=0.001). It also showed a significant correlation with hfPWV in patients with diabetes (r=0.301, P=0.002), but not in patients without diabetes (r=0.115, P=0.055). By multiple linear regression analysis, the log-transformed sRAGE was independently correlated with hfPWV (β=0.13, P=0.004) when controlled for other variables. CONCLUSIONS: This study has demonstrated, for the first time, that serum sRAGE level was independently correlated with a marker of central aortic stiffness. This result suggests the potential role of RAGE in the pathogenesis of aortic stiffness.

Original languageEnglish
Pages (from-to)85-90
Number of pages6
JournalCoronary artery disease
Volume23
Issue number2
DOIs
Publication statusPublished - 2012 Mar 1

Fingerprint

Vascular Stiffness
Pulse Wave Analysis
Advanced Glycosylation End Product-Specific Receptor
Cell Surface Receptors
Thigh
C-Reactive Protein
Linear Models
Protein Isoforms
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Yoon, Se Jung ; Park, Sungha ; Park, Chanmi ; Chang, Woochul ; Cho, Deok Kyu ; Ko, Young Guk ; Choi, Donghoon ; Kwon, Hyuck Moon ; Jang, Yangsoo ; Chung, Namsik. / Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients. In: Coronary artery disease. 2012 ; Vol. 23, No. 2. pp. 85-90.
@article{62256e510e364b8fb510d427e9f76a0d,
title = "Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients",
abstract = "OBJECTIVES: In humans, a secreted isoform of (soluble) receptor for advanced glycation end-products (sRAGE) may act as a decoy receptor of advanced glycation end-product. The level of sRAGE may reflect the activity of cell surface receptor for advanced glycation end-product. But there has been no study that has demonstrated the association of sRAGE with central aortic stiffness. Here, we studied the relation of plasma sRAGE level and arterial pulse wave velocity in hypertensive patients. MATERIALS AND METHODS: A total of 415 patients were enrolled (men; 57.6{\%}, mean age; 53.2±10.8 years), with 25.8{\%} (n=107) of these being diabetic. All patients underwent pulse wave velocity (PWV) and blood sampling of sRAGE, high-sensitive C-reactive protein, and other serologic markers. RESULTS: The log-transformed sRAGE was significantly correlated with the marker of central aortic stiffness heart to femoral PWV (hfPWV; r=0.165, P=0.001). It also showed a significant correlation with hfPWV in patients with diabetes (r=0.301, P=0.002), but not in patients without diabetes (r=0.115, P=0.055). By multiple linear regression analysis, the log-transformed sRAGE was independently correlated with hfPWV (β=0.13, P=0.004) when controlled for other variables. CONCLUSIONS: This study has demonstrated, for the first time, that serum sRAGE level was independently correlated with a marker of central aortic stiffness. This result suggests the potential role of RAGE in the pathogenesis of aortic stiffness.",
author = "Yoon, {Se Jung} and Sungha Park and Chanmi Park and Woochul Chang and Cho, {Deok Kyu} and Ko, {Young Guk} and Donghoon Choi and Kwon, {Hyuck Moon} and Yangsoo Jang and Namsik Chung",
year = "2012",
month = "3",
day = "1",
doi = "10.1097/MCA.0b013e32834f114e",
language = "English",
volume = "23",
pages = "85--90",
journal = "Coronary Artery Disease",
issn = "0954-6928",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients. / Yoon, Se Jung; Park, Sungha; Park, Chanmi; Chang, Woochul; Cho, Deok Kyu; Ko, Young Guk; Choi, Donghoon; Kwon, Hyuck Moon; Jang, Yangsoo; Chung, Namsik.

In: Coronary artery disease, Vol. 23, No. 2, 01.03.2012, p. 85-90.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients

AU - Yoon, Se Jung

AU - Park, Sungha

AU - Park, Chanmi

AU - Chang, Woochul

AU - Cho, Deok Kyu

AU - Ko, Young Guk

AU - Choi, Donghoon

AU - Kwon, Hyuck Moon

AU - Jang, Yangsoo

AU - Chung, Namsik

PY - 2012/3/1

Y1 - 2012/3/1

N2 - OBJECTIVES: In humans, a secreted isoform of (soluble) receptor for advanced glycation end-products (sRAGE) may act as a decoy receptor of advanced glycation end-product. The level of sRAGE may reflect the activity of cell surface receptor for advanced glycation end-product. But there has been no study that has demonstrated the association of sRAGE with central aortic stiffness. Here, we studied the relation of plasma sRAGE level and arterial pulse wave velocity in hypertensive patients. MATERIALS AND METHODS: A total of 415 patients were enrolled (men; 57.6%, mean age; 53.2±10.8 years), with 25.8% (n=107) of these being diabetic. All patients underwent pulse wave velocity (PWV) and blood sampling of sRAGE, high-sensitive C-reactive protein, and other serologic markers. RESULTS: The log-transformed sRAGE was significantly correlated with the marker of central aortic stiffness heart to femoral PWV (hfPWV; r=0.165, P=0.001). It also showed a significant correlation with hfPWV in patients with diabetes (r=0.301, P=0.002), but not in patients without diabetes (r=0.115, P=0.055). By multiple linear regression analysis, the log-transformed sRAGE was independently correlated with hfPWV (β=0.13, P=0.004) when controlled for other variables. CONCLUSIONS: This study has demonstrated, for the first time, that serum sRAGE level was independently correlated with a marker of central aortic stiffness. This result suggests the potential role of RAGE in the pathogenesis of aortic stiffness.

AB - OBJECTIVES: In humans, a secreted isoform of (soluble) receptor for advanced glycation end-products (sRAGE) may act as a decoy receptor of advanced glycation end-product. The level of sRAGE may reflect the activity of cell surface receptor for advanced glycation end-product. But there has been no study that has demonstrated the association of sRAGE with central aortic stiffness. Here, we studied the relation of plasma sRAGE level and arterial pulse wave velocity in hypertensive patients. MATERIALS AND METHODS: A total of 415 patients were enrolled (men; 57.6%, mean age; 53.2±10.8 years), with 25.8% (n=107) of these being diabetic. All patients underwent pulse wave velocity (PWV) and blood sampling of sRAGE, high-sensitive C-reactive protein, and other serologic markers. RESULTS: The log-transformed sRAGE was significantly correlated with the marker of central aortic stiffness heart to femoral PWV (hfPWV; r=0.165, P=0.001). It also showed a significant correlation with hfPWV in patients with diabetes (r=0.301, P=0.002), but not in patients without diabetes (r=0.115, P=0.055). By multiple linear regression analysis, the log-transformed sRAGE was independently correlated with hfPWV (β=0.13, P=0.004) when controlled for other variables. CONCLUSIONS: This study has demonstrated, for the first time, that serum sRAGE level was independently correlated with a marker of central aortic stiffness. This result suggests the potential role of RAGE in the pathogenesis of aortic stiffness.

UR - http://www.scopus.com/inward/record.url?scp=84857239314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857239314&partnerID=8YFLogxK

U2 - 10.1097/MCA.0b013e32834f114e

DO - 10.1097/MCA.0b013e32834f114e

M3 - Review article

C2 - 22198512

AN - SCOPUS:84857239314

VL - 23

SP - 85

EP - 90

JO - Coronary Artery Disease

JF - Coronary Artery Disease

SN - 0954-6928

IS - 2

ER -